BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35749525)

  • 21. Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients.
    Wang SE; Sun YD; Zhao SJ; Wei F; Yang G
    Math Biosci Eng; 2019 Sep; 17(1):92-104. PubMed ID: 31731341
    [No Abstract]   [Full Text] [Related]  

  • 22. Postmastectomy radiotherapy benefit in Chinese breast cancer patients with T1-T2 tumor and 1-3 positive axillary lymph nodes by molecular subtypes: an analysis of 1369 cases.
    Shen H; Zhao L; Wang L; Liu X; Liu X; Liu J; Niu F; Lv S; Niu Y
    Tumour Biol; 2016 May; 37(5):6465-75. PubMed ID: 26631044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of postmastectomy radiotherapy on survival in different age groups for patients with T3N0M0 breast cancer.
    He MT; Lu XX; Gou ZC
    Breast; 2021 Dec; 60():247-254. PubMed ID: 34808436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of postmastectomy radiotherapy on survival outcomes of patients with metaplastic breast cancer].
    Cai W; Zhuang Y; Chen J; Wang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Nov; 41(11):1733-1740. PubMed ID: 34916202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postmastectomy radiation and mortality in women with T1-2 node-positive breast cancer.
    Smith BD; Smith GL; Haffty BG
    J Clin Oncol; 2005 Mar; 23(7):1409-19. PubMed ID: 15735117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic factors for breast cancer patients with T1-2 tumors and 1-3 positive lymph nodes and the role of postmastectomy radiotherapy in these patients.
    Zhao JM; An Q; Sun CN; Li YB; Qin ZL; Guo H; Zeng X; Zhang YT; Wei LL; Han N; Sun SC; Zhang N
    Breast Cancer; 2021 Mar; 28(2):298-306. PubMed ID: 32940902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
    Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
    Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of postmastectomy radiation therapy in T1-2 breast cancer patients with 1-3 positive axillary lymph nodes.
    Yin H; Qu Y; Wang X; Ma T; Zhang H; Zhang Y; Li Y; Zhang S; Ma H; Xing E; Liu X; Xu Q
    Oncotarget; 2017 Jul; 8(30):49564-49573. PubMed ID: 28484094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The clinical value of adjuvant radiotherapy in patients with early stage breast cancer with 1 to 3 positive lymph nodes after mastectomy.
    Wu SG; He ZY; Li FY; Wang JJ; Guo J; Lin Q; Guan XX
    Chin J Cancer; 2010 Jul; 29(7):668-76. PubMed ID: 20591219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should all breast cancer patients with four or more positive lymph nodes who underwent modified radical mastectomy be treated with postoperative radiotherapy? A population-based study.
    Wang H; Kong L; Zhang C; Chen D; Zhu H; Yu J
    Oncotarget; 2016 Nov; 7(46):75492-75502. PubMed ID: 27690343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postmastectomy Radiotherapy Improves Survival Benefits in De Novo Stage IV Breast Cancer: A Propensity-Score Matched Analysis.
    Wang X; Liang N; Tian T; Zhang J; Hu P
    Technol Cancer Res Treat; 2022; 21():15330338221089937. PubMed ID: 35491730
    [No Abstract]   [Full Text] [Related]  

  • 32. Selection criteria for postmastectomy radiotherapy in t1-t2 tumors with 1 to 3 positive lymph nodes.
    Moo TA; McMillan R; Lee M; Stempel M; Patil S; Ho A; El-Tamer M
    Ann Surg Oncol; 2013 Oct; 20(10):3169-74. PubMed ID: 23975289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T1-2N0M0 Triple-Negative Breast Cancer Treated With Breast-Conserving Therapy Has Better Survival Compared to Mastectomy: A SEER Population-Based Retrospective Analysis.
    Li H; Chen Y; Wang X; Tang L; Guan X
    Clin Breast Cancer; 2019 Dec; 19(6):e669-e682. PubMed ID: 31375327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 21-Gene Recurrence Score Assay Predicts Benefit of Post-Mastectomy Radiotherapy in T1-2 N1 Breast Cancer.
    Goodman CR; Seagle BL; Kocherginsky M; Donnelly ED; Shahabi S; Strauss JB
    Clin Cancer Res; 2018 Aug; 24(16):3878-3887. PubMed ID: 29685878
    [No Abstract]   [Full Text] [Related]  

  • 35. Assessment of Use and Impact of Chemotherapy in Lymph Node-Negative, T1a Triple-Negative Breast Cancer.
    Bravo-Solarte DC; Zhang F; Anampa JD
    Clin Breast Cancer; 2023 Oct; 23(7):763-773.e6. PubMed ID: 37648557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of postmastectomy radiotherapy on pT
    Guo XY; Sun GY; Wang HM; Liu M; Zhang YJ; Zhang N; Tang Y; Zhao XR; Jing H; Fang H; Wen G; Guo QS; Wu HF; Wang XH; Ma CY; Li YX; Cheng J; Shi M; Wang SL
    Breast; 2022 Feb; 61():108-117. PubMed ID: 34942430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Locoregional Recurrence Risk for Postmastectomy Breast Cancer Patients With T1-2 and One to Three Positive Lymph Nodes Receiving Modern Systemic Treatment Without Radiotherapy.
    Lai SF; Chen YH; Kuo WH; Lien HC; Wang MY; Lu YS; Lo C; Kuo SH; Cheng AL; Huang CS
    Ann Surg Oncol; 2016 Nov; 23(12):3860-3869. PubMed ID: 27436202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 Trial.
    Zeidan YH; Habib JG; Ameye L; Paesmans M; de Azambuja E; Gelber RD; Campbell I; Nordenskjöld B; Gutiérez J; Anderson M; Lluch A; Gnant M; Goldhirsch A; Di Leo A; Joseph DJ; Crown J; Piccart-Gebhart M; Francis PA
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):316-324. PubMed ID: 29534902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Most Breast Cancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need Postmastectomy Radiotherapy.
    Muhsen S; Moo TA; Patil S; Stempel M; Powell S; Morrow M; El-Tamer M
    Ann Surg Oncol; 2018 Jul; 25(7):1912-1920. PubMed ID: 29564588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Benefit of adjuvant chemotherapy in lymph node-negative, T1b and T1c triple-negative breast cancer.
    Carbajal-Ochoa W; Bravo-Solarte DC; Bernal AM; Anampa JD
    Breast Cancer Res Treat; 2024 Jan; 203(2):257-269. PubMed ID: 37833449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.